Published Mar 13, 2024

Drew Taylor from Acorn Biolabs

Drew Taylor, Co-Founder and CEO of Acorn Biolabs, shares his compelling journey from MLB pitcher to entrepreneur in regenerative medicine, discussing the transformative potential of stem cells and the future of healthcare with cutting-edge innovations in cellular treatments aimed at enhancing longevity and healthspan.
Episode Highlights
The Hard Part with Evan McCann logo

Popular Clips

Questions from this episode

Episode Highlights

  • Standard Care

    The future of regenerative medicine is poised to make storing younger cells a standard healthcare practice. believes that as applications for stem cells become more widespread, insurance companies might cover the costs of cell banking, reducing overall healthcare expenses 1. He envisions a future where leveraging stem cells will not only treat diseases but also maintain health and performance as we age.

    I think saving our younger materials is going to become a standard of care.

    ---

    The acceleration of innovation in this field is comparable to the rapid advancements seen in aviation history, suggesting that significant breakthroughs are imminent 2.

       

    Healthcare Innovations

    Acorn Biolabs is at the forefront of healthcare innovation with its specialized facilities designed for cell processing and storage. describes their clean room laboratories and cryogenic storage systems, which ensure the safety and maintenance of stored cells 3. By collaborating with existing infrastructure at hospitals and universities, Acorn efficiently expands its operations across multiple sites.

    We run a very fantastic facility because it's automatic top up, and all of these different pipings that make this system have a lot of checks and balances.

    ---

    The company also emphasizes rigorous clinical trials to ensure patient safety and efficacy of treatments, highlighting the complexity and dedication required in this innovative space 4.

Related Episodes